The impact of old versus new antiepileptic drugs on costs and patient reported outcomes among older adults.

Related Articles

The impact of old versus new antiepileptic drugs on costs and patient reported outcomes among older adults.

Geriatr Nurs. 2018 11;39(6):669-675

Authors: Almalag HM, Alzahrani H, Al-Hussain F, Alsemari A, De Vol EB, Almarzouqi MR, AlRuthia YS

Abstract
The aim of this prospective questionnaire-based cross-sectional study was to examine whether the new generation of Antiepileptic drugs (AEDs) with higher acquisition cost generate lower adverse effects than the old AEDs among a sample of 102 Arabic-speaking older adults (60 years of age or older) with seizure disorders. The mean scores of the Arabic version of the Liverpool Adverse Events Profile (LAEP), which assessed the adverse effects of the AEDs, did not differ between patients taking the old and new generations of AEDs. Despite their 4-fold higher cost, the new generation of AEDs were not characterized by lower LAEP scores of adverse effects. However, higher LAEP scores were associated with better health literacy. In conclusion, the use of new AEDs was not associated with lower self-reported adverse effects scores among Arabic-speaking older adults with seizure disorders despite their higher acquisition costs.

PMID: 29859697 [PubMed - indexed for MEDLINE]

from A via a.sfakia on Inoreader http://bit.ly/2Gchl6u